Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical ...
The deal will allow Abbott — which makes continuous glucose monitors and other products — to enter the cancer testing space.
Business Insider's exclusive analysis shows colon cancer in your 30s can cost $45,000 in one year alone. We break it down, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback